Wenlong Liu

Also affiliated with Heilongjiang University of Chinese Medicine, Johns Hopkins Medicine, Institute for Safe Medication Practices, National Cancer Institute, University of Hong Kong

EngineeringBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy”.

RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy

Antibody Therapeutics(2025)10.1093/abt/tbaf022

N/A

0DataRank · unranked

2 citations

Xiufen Liu, Wenlong Liu, Jingyu Zhan, Carolyn Maslanka, Di Xia +3 more

Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013537

N/A

0DataRank · unranked

0 citations

Branden S. Moriarity, Beau R. Webber, Wenlong Liu